Corporate Banner
Satellite Banner
Technology Networks Header
Friday, October 31, 2014
 
Register | Sign in
Home Page > Videos > Vertex Pipette Tips
  Videos

Return

Vertex Pipette Tips
SSI Robotics

Vertex™ Pipette Tips – Range of low-retention tips developed specifically for life science researchers. SSI, an American manufacturer of consumable plastics for laboratory researchers for over 23 years has launched a new comprehensive family of pipette tips designed to provide researchers with the highest level of liquid handling performance. The Vertex™ Pipette Tips were developed following extensive research to provide users with a high degree of fluid confidence and control while pipetting. SSI internal studies have indicated their tips provide less fluid retention and less sample loss. All Vertex tips are manufactured using SSI’s specially formulated NoStick® resin. Through use of this resin, the inner surface of the tip is considerably more hydrophobic than standard industry tips enabling viscous fluids in particular to be dispensed more completely. The finely tapered tip construction and thinner walls eliminate the need for users to touch off their pipettor. Researchers maintain more pipetting control in general, but especially when working with smaller volumes. SSI has produced a short video detailing their new Vertex™ Pipette Tips. It can be found on their microsite (www.vertextips.com). The new range of tips includes bulk, racked, sterile, and EcoPac® (refill insert) options. They are producing Un-Filtered and Filtered varieties in 10µl, 10µlXL, 200µl, 300µl, 1mL and 1250µl sizes. The Vertex line includes a time-saving EcoPac® Refill System. The new system does not require any tools or special instructions to enable users to move from an empty insert to a fresh set of 96 tips. The Vertex racks were uniquely designed for one-hand operation. A simple press on the front of the lid releases it from the rack; otherwise the lid sits securely closed. The EcoPac refills provide over a 70% savings in total materials (including products and packaging). Since 1990 SSI has been developing and producing innovations for life science at their California home office. They operate under an ISO9001 certified Quality Assurance process and deploy state of the art fully automated manufacturing. SSI disposable products are sold through laboratory supply distributors worldwide.

Request more information
Company product page



For access to this article, enter your email address to instantly recieve a Password Reset link.

Please enter your email address below:

Existing users please Sign In here. Don't have an account? Register Here for free access.

Don't have an account? | Register Here

Scientific News
Eppendorf Award for Young European Investigators 2015: Call for Entries!
Eppendorf Award celebrates 20 years in 2015.
Scientists Generate First Human Stomach Tissue in Lab with Stem Cells
Unprecedented tool for researching the development and diseases of an organ central to several public health crises.
Accelerating Spirocyclic Polyketide Synthesis
Powerful flow chemistry techniques used for complex multi-stage synthesis of spirocyclic polyketides.
MS Drug Candidate Shows Promise for Ulcerative Colitis
Positive new clinical data were released today on a drug candidate for ulcerative colitis that was first discovered and synthesized at The Scripps Research Institute.
First Atlas of Body Clock Gene Expression in Mammals Informs Timing of Drug Delivery
Penn Medicine study has implications for 100 top-selling US drugs, half of which target daily-oscillating genes.
New Technique has Profound Implications for Drug Development
The method, developed by Scripps Research Institute chemists, expands options for making pure batches of ‘one-handed’ molecules.
Blood Test Developed to Diagnose Early Onset Alzheimer’s Disease
New blood-test could predict a person’s risk of developing AD much earlier than is currently possible.
Tea and Citrus Products Could Lower Ovarian Cancer Risk
New UEA research finds that women who consume foods containing flavonols and flavanones significantly decrease their risk of developing epithelial ovarian cancer.
TxCell Achieves Positive Results for Col-Treg in a Model of Autoimmune Uveitis
TxCell set for phase I/II proof of principle clinical study in Q2 2015 for its second therapeutic candidate in this rare eye disease.
Heart Drug May Help Treat ALS, Mouse Study Shows
Scientists blocked the enzyme in ALS astrocytes using digoxin, a medication used in the treatment of heart failure.
Scroll Up
Scroll Down
Skyscraper Banner
Skyscraper Banner
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Go to LabTube.tv